Enantioselective Allylic Alkylation Catalysed by Cationic Pd Complexes
FULL PAPER
chromatography (SiO2; hexane/ethyl acetate with increasing po-
larity) with dr Ͼ 95:5 and were used as such in the subsequent step.
For analytical purposes, the pure diastereomers were obtained by
repeated chromatography with slightly decreased yield. No attempt
was made to isolate the minor diastereomers as they could not be
isolated in a pure state by column chromatography.
Preparation of the Aziridines 24a–c: A solution of 1,2-amino
alcohol (3 mmol) and 1,1Ј-carbonyldiimidazole (0.540 g, 3.3 mmol)
in dry CH2Cl2 (10 mL) was stirred at room temperature for 1.5 h,
then the solvent was evaporated and the yellow-brown residue was
dissolved in a 1:3 THF/H2O mixture (80 mL). The mixture was
vigorously stirred overnight, then THF was evaporated under re-
duced pressure and the organic phase was extracted with Et2O
(3×30 mL). The collected organic phases were dried (Na2SO4),
(S)-N-[(S)-2-Methyl-1-(2-quinolyl)propyl]valinol (23a): Yellowish
oil; 0.215 g (25%). [α]2D0 = –70.7 (c = 1.05, CHCl3). 1H NMR
(200 MHz, CDCl3): δ = 8.08 (dd, J = 5.4 and 8.0 Hz, Ar), 7.80 (dd, then evaporated to leave an oily residue, which was chromato-
J = 1.2 and 8.0 Hz, 1 H, Ar), 7.70 (m, 1 H, Ar), 7.51 (m, 1 H, Ar),
7.31 (d, J = 8.4 Hz, 1 H, Ar), 3.70 (dd, J = 3.6 and 10.6 Hz, 1 H,
CH2O), 3.61 (d, J = 6.6 Hz, 1 H, ArCHN), 3.45 (dd, J = 3.8 and
10.8 Hz, 1 H, CH2OH), 2.5 (broad, 2 H, OH and NH), 2.13 (m, 1
H, CHN), 2.06 (m, 1 H, CHMe2), 1.32 (s, 1 H, NH), 1.65 (m, 1 H,
CHMe2), 1.04 (d, J = 6.6 Hz, 3 H, CHMe2), 0.86, 0.84 and 0.77 (3
d, J = 7.0 Hz, 9 H, CHMe2) ppm. GC-MS: m/z (%) = 243 (100)
[M+ – iPr], 184 (98), 142 (51), 199 (50), 154 (30), 158 (28), 157 (20),
169 (19), 170 (18), 255 (10) [M+ – CH2OH]. C18H26N2O: calcd. C
75.48; H 9.15, N 9.78; found C 75.55, H 9.18, N 9.70.
(S)-N-[(S)-2-methyl-1-(8-quinolyl)propyl]valinol (23b): Yellowish oil;
0.325 g (1.14 mmol, 38%). [α]2D0 = –49.1 (c = 1.05, CHCl3). 1H
NMR (200 MHz, CDCl3): δ = 8.87 (dd, J = 1.8 and 4.4 Hz, Ar),
8.16 (dd, J = 1.8 and 8.4 Hz, 1 H, Ar), 7.72 (m, 1 H, Ar), 7.47 (d,
J = 5.2 Hz, 2 H, Ar), 7.39 (dd, J = 4.4 and 8.0 Hz, 1 H, Ar), 3.95
(broad, 1 H, OH), 3.71 (dd, J = 4.0 and 10.6 Hz, 1 H, CH2O), 3.43
(dd, J = 1.8 and 10.6 Hz, 1 H, CH2O), 2.55 (m, 2 H, ArCHN and
NH), 1.99 (m, 1 H, CHMe2), 1.55 (m, 1 H, CHMe2), 1.24 (d, J =
6.6 Hz, 3 H, CHMe), 0.64, 0.59 and 0.56 (3 d, J = 6.6 Hz, 9 H,
CHMe2) ppm. GC-MS: m/z (%) = 243 (100) [M+ – iPr], 184 (98),
142 (51), 199 (51), 158 (28), 154 (26), 157 (20), 167 (19), 168 (18).
C18H26N2O: calcd. C 75.48; H 9.15, N 9.78; found C 75.34, H 9.17,
N 9.72.
(S)-N-[(S)-1-(6-Benzyl-2-pyridyl)-2-methylpropyl]valinol (23c): Yel-
lowish oil; 0.546 g (56%). [α]2D0 = –64.4 (c = 0.68, CHCl3). 1H NMR
(200 MHz, CDCl3): δ = 7.49 (t, J = 7.6 Hz, 1 H, Py), 7.36–7.14 (m,
5 H, Ph), 6.94 (t, J = 7.6 Hz, 2 H, Py), 4.14 (s, 2 H, CH2Ph), 3.60
and 3.41 (2 dd, J = 3.8 and 10.8 Hz, 2 H, CH2O), 3.30 (d, J =
7.4 Hz, 1 H, ArCHN), 2.15 (m, 1 H, NCHCH2), 1.96 and 1.56 (2
m, 2 H, CHMe2), 1.42 (broad, 2 H, NH and OH), 1.04, 0.77, 0.75
and 0.74 (4 d, J = 7.0 Hz, 12 H, CHMe2) ppm. C21H30N2O: calcd.
C 77.25; H 9.26, N 8.58; found C 77.33, H 9.32, N 8.52. The pro-
duct decomposed during the GC-MS analysis.
graphed on a SiO2 column, eluting with cyclohexane/ethyl acetate
mixtures.
(S)-1-[(S)-2-Methyl-1-(2-quinolyl)propyl]isopropylaziridine
(24a):
Yellowish oil; 0.507 g (63%), dr = 95:5 (GC/MS). [α]2D0 = –32.6 (c
= 1.05, CHCl3). 1H NMR (200 MHz, CDCl3): δ = 8.12 (dd, J =
8.8 Hz and 15.8 Hz, 1 H, Ar), 7.82 (d, J = 8.0 Hz, 1 H, Ar), 7.71
(d, J = 8.4 Hz, 2 H, Ar), 7.53 (t, J = 7.6 Hz, 1 H, Ar), 2.41 (m, 1
H, NCHCH2), 2.20 (d, J = 8.5 Hz, 1 H, PyCH), 1.85 (d, J = 3.6
Hz, 1 H, NCH2), 1.64 (d, J = 6.2 Hz, 1 H, NCH2), 1.22 (d, J =
5.6 Hz, 3 H, CHMe2), 1.22 (m, 1 H, CHMe2), 1.15 (m, 1 H,
CHMe2), 0.74 (t, J = Hz, 6 H, CHMe2), 0.35 (d, J = 6.4 Hz, 3 H,
ArCHCHMe2) ppm. GC-MS: m/z (%) = 155 (100), 197 (60), 142
(50), 168 (22), 225 (18) [M+ – iPr]. C18H24N2: calcd. C 80.55; H
9.01, N 10.40; found C 80.59, H 9.06, N 10.42.
(S)-1-[(S)-2-Methyl-1-(8-quinolyl)propyl]isopropylaziridine
(24b):
Yellowish oil; 0.523 g (65%), dr = 96:4 (GC/MS). [α]2D0 = +15.7 (c
1
= 0.53, CHCl3). H NMR (200 MHz, CDCl3): δ = 8.89 (m, 1 H,
Ar), 8.15 (d, J = 8.1 Hz, 1 H, Ar), 8.05 (d, J = 6.4 Hz, 1 H, Ar),
7.70 (d, J = 8.1 Hz, 1 H, Ar), 7.60 (m, 1 H, Ar), 7.38 (m, 1 H, Ar),
3.86 (d, J = 8.7 Hz, 1 H, ArCHN), 2.38 (m, 1 H, NCHCH2), 1.80
(m, 2 H, NCHCH2), 1.22 (d, J = 6.6 Hz, 3 H, CHMe2), 1.03 (m,
2 H, CHMe2), 0.67 and 0.66 (2 d, J = 6.6 Hz, 6 H, CHMe2), 0.26
(d, J = 6.6 Hz, 3 H, CHMe2) ppm. GC-MS: m/z (%) = 155 (100),
197 (60), 142 (50), 225 (18), 168 (15), 184 (13), 268 (10) [M+], 253
(5). C18H24N2: calcd. C 80.55; H 9.01, N 10.44; found C 80.61, H
9.03, N 10.42.
(S)-1-[(S)-1-(6-Benzyl-2-pyridyl)-2-methylpropyl]isopropylaziridine
(24c): Yellowish oil; 0.545 g (59%), dr 98:2 (GC/MS). [α]2D0 = –44.5
1
(c = 0.63, CHCl3). H NMR (200 MHz, CDCl3): δ = 7.53 (t, J =
7.8 Hz, 1 H, 7.35–7–13 (m, 6 H, Ar), 6.93 (d, J = 7.8 Hz, 1 H, Py),
4.14 (s, 2 H, CH2Ph), 2.28 (m, 1 H, CHCH2), 2.18 (d, J = 8.8 Hz,
1 H, NCHAr), 1.77 (d, J = 3.6 Hz, 1 H, CHCH2), 1.54 (d, J =
6.2 Hz, 1 H, CHCH2), 1.20 and 1.05 (2 m, 2 H, CHMe2), 1.14,
0.74, 0.69 and 0.34 (4 d, J = 6.6 Hz, 12 H, CHMe2) ppm. GC-MS:
m/z (%) = 225 (100), 265 (88), 210 (58), 84 (47), 236 (35), 197 (33),
91 (20), 55 (17), 182 (16), 167 (13). C21H28N2: calcd. C 81.77; H
9.15, N 9.08; found C 81.83, H 9.18, N 9.04.
Preparation of [(N,NЈ)*(η3-allyl)Pd][SbF6] Complexes: Allylpalla-
dium chloride dimer (0.157 g, 0.43 mmol) was added to a solution
of the aziridine (0.86 mmol) in CH2Cl2 (15 mL). After stirring for
1 h the solution became green, then a solution of silver hexafluo-
roantimonate (0.300 g, 0.86 mmol) in THF (6 mL) was added and
the mixture was stirred for 30 min, during which time a white pre-
cipitate formed. The solid was filtered off through a small pad of
celite. The organic phase was washed with brine, dried (Na2SO4)
and evaporated to leave a solid residue, which was then crystallised.
Complex 12 has been described previously.[8]
(R)-1-[(R)-2-methyl-1-(2-pyridyl)propyl]phenylaziridine (19): Trieth-
ylamine (0.755 g, 7.4 mmol) and methanesulfonyl chloride (0.493 g,
4,44 mmol) were added to a solution of the diastereomerically pure
amino alcohol 17 (0.400 g, 1.48 mmol) in CH2Cl2 (12 mL) cooled
to –78 °C and the mixture was stirred for 3 h. After quenching
with sat. NaHCO3 (5 mL), the organic layer was separated and the
organic bases were extracted from the aqueous layer with CH2Cl2
(3×5 mL). The collected organic layers were dried (CaCl2) and
concentrated to leave an oil, which was chromatographed on a SiO2
column eluting with cyclohexane/ethyl acetate (85:15) to obtain
compound 19 as a yellowish oil. Yield: 0.202 g, (55%). [α]2D0
=
1
–129.6 (c = 0.44, CHCl3). H NMR (300 MHz, CDCl3): δ = 8.51
(d, J = 4.5 Hz, 1 H, Py), 7.56 (dt, J = 1.5 and 7.5 Hz, 1 H, Py),
7.42 (d, J = 7.5 Hz, 1 H, Py), 7.35–7.0 (m, 6 H, Ar), 2.71 (d, J =
6.0 Hz, 1 H, NCHPy), 2.35 (dd, J = 3.3 and 6.5 Hz, PhCHCH2),
2.28 (m, 1 H, CHMe2), 2.16 (d, J = 3.3 Hz, 1.H, CHCH2), 2.02 (d, Complex 20: Colourless crystals (CH2Cl2/Et2O), 57% yield; m.p.
J = 6.5 Hz, 1 H, CHCH2), 1.10 and 0.97 (2 d, J = 6.6 Hz, 6 H,
CHMe2) ppm. GC-MS: m/z (%) = 118 (100) [PhCHCH2N], 91 (86),
213–214 °C (dec.). [α]2D0 = –31.6 (c = 0.4, CHCl3). The 1H NMR
spectrum (300 MHz, CDCl3) shows the presence of two rotamers
136 (21), 119 (8), 78 (6), 182 (5), 104 (5), 209 (4) [M+ – iPr]. in a 60:40 ratio (the absorptions of the prevalent rotamer are re-
C17H20N2: calcd. C 80.91, H 7.99, N 11.10; found C 80.97, H 8.04,
N 11.05.
ported in bold): δ = 8.58 and 8.46 (2 d, J = 5.6 Hz, 1 H, Ar), 8.08
(m, 1 H, Ar), 7.77 (m, 1 H, Ar), 7.52 (m, 1 H, Ar), 7.47 (m, 1 H,
Eur. J. Org. Chem. 2005, 1416–1426
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1423